Irrespective of the ER status, tumours in the high-risk group had significantly lower expression levels of JAK2, CXCR6, STAT6, IL6ST, IRF2, GBP2, TP53 and TP63 (P ≤0.05, Figure 6A). This evidence concerns the gene IRF2 and neoplasm.